

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | postsynaptic membrane organization (GO:0001941) | 4.69075611 |
| 2 | respiratory chain complex IV assembly (GO:0008535) | 4.64095271 |
| 3 | inositol phosphate catabolic process (GO:0071545) | 4.60209724 |
| 4 | inositol phosphate dephosphorylation (GO:0046855) | 4.55694923 |
| 5 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.55694923 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.44593501 |
| 7 | cytochrome complex assembly (GO:0017004) | 4.41305094 |
| 8 | cellular ketone body metabolic process (GO:0046950) | 4.30045029 |
| 9 | membrane assembly (GO:0071709) | 4.27351907 |
| 10 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.27011633 |
| 11 | ketone body metabolic process (GO:1902224) | 4.21961083 |
| 12 | regulation of Rac protein signal transduction (GO:0035020) | 4.16786079 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.00869026 |
| 14 | polyol catabolic process (GO:0046174) | 3.92575050 |
| 15 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.89668463 |
| 16 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.85554133 |
| 17 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.83998888 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 3.71223217 |
| 19 | regulation of axon regeneration (GO:0048679) | 3.60485418 |
| 20 | regulation of neuron projection regeneration (GO:0070570) | 3.60485418 |
| 21 | protein localization to synapse (GO:0035418) | 3.59177270 |
| 22 | vocalization behavior (GO:0071625) | 3.58328968 |
| 23 | protein prenylation (GO:0018342) | 3.55063957 |
| 24 | prenylation (GO:0097354) | 3.55063957 |
| 25 | positive regulation of gluconeogenesis (GO:0045722) | 3.54103356 |
| 26 | response to pheromone (GO:0019236) | 3.49169913 |
| 27 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.41598573 |
| 28 | glycerophospholipid catabolic process (GO:0046475) | 3.41101331 |
| 29 | platelet dense granule organization (GO:0060155) | 3.38277826 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.35254420 |
| 31 | neuron remodeling (GO:0016322) | 3.34013966 |
| 32 | magnesium ion transport (GO:0015693) | 3.33383812 |
| 33 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.31136541 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.27167316 |
| 35 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25980406 |
| 36 | regulation of B cell apoptotic process (GO:0002902) | 3.24123158 |
| 37 | auditory receptor cell differentiation (GO:0042491) | 3.22843735 |
| 38 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.22126475 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.21704456 |
| 40 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.20763411 |
| 41 | insulin secretion (GO:0030073) | 3.20268824 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.14011619 |
| 43 | protein complex biogenesis (GO:0070271) | 3.14000583 |
| 44 | regulation of glucokinase activity (GO:0033131) | 3.13981318 |
| 45 | regulation of hexokinase activity (GO:1903299) | 3.13981318 |
| 46 | S-adenosylmethionine metabolic process (GO:0046500) | 3.10999789 |
| 47 | parental behavior (GO:0060746) | 3.10149267 |
| 48 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.01647483 |
| 49 | regulation of neurotransmitter uptake (GO:0051580) | 3.01606728 |
| 50 | nitric oxide biosynthetic process (GO:0006809) | 2.98693308 |
| 51 | synapsis (GO:0007129) | 2.97215641 |
| 52 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.97207194 |
| 53 | positive regulation of glycolytic process (GO:0045821) | 2.96287648 |
| 54 | axoneme assembly (GO:0035082) | 2.95502244 |
| 55 | serotonin receptor signaling pathway (GO:0007210) | 2.95024687 |
| 56 | regulation of pigment cell differentiation (GO:0050932) | 2.94694450 |
| 57 | heme transport (GO:0015886) | 2.89743813 |
| 58 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.87505572 |
| 59 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.87247897 |
| 60 | negative regulation of complement activation (GO:0045916) | 2.86257784 |
| 61 | facial nerve structural organization (GO:0021612) | 2.86003812 |
| 62 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.85932529 |
| 63 | signal peptide processing (GO:0006465) | 2.85553102 |
| 64 | regulation of glutamate secretion (GO:0014048) | 2.85021135 |
| 65 | neuronal action potential propagation (GO:0019227) | 2.84532194 |
| 66 | L-phenylalanine catabolic process (GO:0006559) | 2.84346162 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.84346162 |
| 68 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.84312193 |
| 69 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.82514880 |
| 70 | sleep (GO:0030431) | 2.82405633 |
| 71 | C-terminal protein lipidation (GO:0006501) | 2.82021856 |
| 72 | proline transport (GO:0015824) | 2.81651841 |
| 73 | synaptic vesicle exocytosis (GO:0016079) | 2.81076601 |
| 74 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.80191219 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.79447088 |
| 76 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.79417385 |
| 77 | positive regulation of calcium ion import (GO:0090280) | 2.78935567 |
| 78 | positive regulation of protein autophosphorylation (GO:0031954) | 2.77502814 |
| 79 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77341070 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 2.76823503 |
| 81 | rRNA methylation (GO:0031167) | 2.75674442 |
| 82 | peptide hormone processing (GO:0016486) | 2.75590749 |
| 83 | xenobiotic catabolic process (GO:0042178) | 2.75484810 |
| 84 | retinol metabolic process (GO:0042572) | 2.75283378 |
| 85 | response to histamine (GO:0034776) | 2.74859105 |
| 86 | neuron-neuron synaptic transmission (GO:0007270) | 2.74251153 |
| 87 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.74089318 |
| 88 | long-term synaptic potentiation (GO:0060291) | 2.73338826 |
| 89 | lactate metabolic process (GO:0006089) | 2.72760931 |
| 90 | branched-chain amino acid catabolic process (GO:0009083) | 2.72264367 |
| 91 | tryptophan catabolic process (GO:0006569) | 2.70136695 |
| 92 | indole-containing compound catabolic process (GO:0042436) | 2.70136695 |
| 93 | indolalkylamine catabolic process (GO:0046218) | 2.70136695 |
| 94 | atrial cardiac muscle cell action potential (GO:0086014) | 2.69698716 |
| 95 | negative regulation of neurological system process (GO:0031645) | 2.68951928 |
| 96 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.67833462 |
| 97 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.67592804 |
| 98 | negative regulation of cation channel activity (GO:2001258) | 2.67444264 |
| 99 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.66645642 |
| 100 | regulation of cilium movement (GO:0003352) | 2.65859494 |
| 101 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.65248137 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.65052535 |
| 103 | L-phenylalanine metabolic process (GO:0006558) | 2.65052535 |
| 104 | synaptic transmission, glutamatergic (GO:0035249) | 2.64588208 |
| 105 | regulation of sulfur metabolic process (GO:0042762) | 2.63858035 |
| 106 | transferrin transport (GO:0033572) | 2.59560912 |
| 107 | positive regulation of neurotransmitter transport (GO:0051590) | 2.59146678 |
| 108 | regulation of dopamine secretion (GO:0014059) | 2.58548361 |
| 109 | glutamate secretion (GO:0014047) | 2.58038598 |
| 110 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56689604 |
| 111 | endosome to melanosome transport (GO:0035646) | 2.56369869 |
| 112 | endosome to pigment granule transport (GO:0043485) | 2.56369869 |
| 113 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.55682261 |
| 114 | fucose catabolic process (GO:0019317) | 2.55418449 |
| 115 | L-fucose metabolic process (GO:0042354) | 2.55418449 |
| 116 | L-fucose catabolic process (GO:0042355) | 2.55418449 |
| 117 | C-terminal protein amino acid modification (GO:0018410) | 2.54868238 |
| 118 | response to amphetamine (GO:0001975) | 2.54366024 |
| 119 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.53988301 |
| 120 | cullin deneddylation (GO:0010388) | 2.53437192 |
| 121 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.52942232 |
| 122 | cranial nerve structural organization (GO:0021604) | 2.52586716 |
| 123 | positive regulation of insulin secretion (GO:0032024) | 2.51601847 |
| 124 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.51373232 |
| 125 | eosinophil chemotaxis (GO:0048245) | 2.50873585 |
| 126 | protein K6-linked ubiquitination (GO:0085020) | 2.50861136 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50623290 |
| 128 | regulation of phospholipase A2 activity (GO:0032429) | 2.50152779 |
| 129 | behavioral response to pain (GO:0048266) | 2.49572681 |
| 130 | aggressive behavior (GO:0002118) | 2.48543482 |
| 131 | iron coordination entity transport (GO:1901678) | 2.48454536 |
| 132 | sphingomyelin metabolic process (GO:0006684) | 2.48144312 |
| 133 | nitric oxide mediated signal transduction (GO:0007263) | 2.47955110 |
| 134 | regulation of vesicle fusion (GO:0031338) | 2.47541867 |
| 135 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.47164691 |
| 136 | protein localization to cilium (GO:0061512) | 2.46514462 |
| 137 | negative regulation of protein activation cascade (GO:2000258) | 2.46384115 |
| 138 | ferric iron transport (GO:0015682) | 2.46349995 |
| 139 | trivalent inorganic cation transport (GO:0072512) | 2.46349995 |
| 140 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.45591539 |
| 141 | prostate gland growth (GO:0060736) | 2.45449467 |
| 142 | positive regulation of synapse assembly (GO:0051965) | 2.44483571 |
| 143 | regulation of execution phase of apoptosis (GO:1900117) | 2.43181517 |
| 144 | protein K11-linked deubiquitination (GO:0035871) | 2.43100400 |
| 145 | DNA deamination (GO:0045006) | 2.43081062 |
| 146 | alanine transport (GO:0032328) | 2.43037533 |
| 147 | negative regulation of monooxygenase activity (GO:0032769) | 2.42681377 |
| 148 | endocrine pancreas development (GO:0031018) | 2.42598614 |
| 149 | startle response (GO:0001964) | 2.42563565 |
| 150 | long term synaptic depression (GO:0060292) | 2.41764007 |
| 151 | extracellular fibril organization (GO:0043206) | 2.41743366 |
| 152 | indolalkylamine metabolic process (GO:0006586) | 2.41602429 |
| 153 | inositol phosphate-mediated signaling (GO:0048016) | 2.41325038 |
| 154 | neuron maturation (GO:0042551) | 2.40557956 |
| 155 | phagosome maturation (GO:0090382) | 2.40339018 |
| 156 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.39785733 |
| 157 | rRNA modification (GO:0000154) | 2.38930759 |
| 158 | glucosamine-containing compound catabolic process (GO:1901072) | 2.38925693 |
| 159 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.38527818 |
| 160 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.36486381 |
| 161 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.36459761 |
| 162 | photoreceptor cell maintenance (GO:0045494) | 2.35914370 |
| 163 | kidney morphogenesis (GO:0060993) | 2.35742227 |
| 164 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.35320896 |
| 165 | nodal signaling pathway (GO:0038092) | 2.35291857 |
| 166 | regulation of metalloenzyme activity (GO:0048552) | 2.34752184 |
| 167 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.34669828 |
| 168 | keratinocyte development (GO:0003334) | 2.34470271 |
| 169 | negative regulation of dendrite development (GO:2000171) | 2.33554333 |
| 170 | dopamine transport (GO:0015872) | 2.33102391 |
| 171 | behavioral response to cocaine (GO:0048148) | 2.32993183 |
| 172 | synaptic transmission, dopaminergic (GO:0001963) | 2.32987086 |
| 173 | serotonin metabolic process (GO:0042428) | 2.32856858 |
| 174 | fear response (GO:0042596) | 2.32378979 |
| 175 | cochlea development (GO:0090102) | 2.31136068 |
| 176 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.28716404 |
| 177 | righting reflex (GO:0060013) | 2.25223316 |
| 178 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.24019386 |
| 179 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.24019386 |
| 180 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.23973472 |
| 181 | positive regulation of response to oxidative stress (GO:1902884) | 2.23973472 |
| 182 | regulation of neurotransmitter secretion (GO:0046928) | 2.23889746 |
| 183 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.23842114 |
| 184 | regulation of synapse assembly (GO:0051963) | 2.22786273 |
| 185 | response to gravity (GO:0009629) | 2.22720792 |
| 186 | learning (GO:0007612) | 2.21973807 |
| 187 | negative regulation of neurotransmitter transport (GO:0051589) | 2.21425171 |
| 188 | regulation of synaptic plasticity (GO:0048167) | 2.21346724 |
| 189 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.20350381 |
| 190 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.20350381 |
| 191 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.19555163 |
| 192 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.16771403 |
| 193 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.16771403 |
| 194 | dopamine biosynthetic process (GO:0042416) | 2.16639144 |
| 195 | female mating behavior (GO:0060180) | 2.15672603 |
| 196 | innervation (GO:0060384) | 2.14861834 |
| 197 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.14376795 |
| 198 | membrane depolarization (GO:0051899) | 2.14341765 |
| 199 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.12743800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.23937053 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84229965 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.40104856 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88310657 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73802029 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73070716 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66379315 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.59180151 |
| 9 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.59055388 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51835636 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.49163537 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.49031128 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.44470616 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.43659512 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.28269485 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.28269485 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.27868860 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22479542 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16257147 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.11365902 |
| 21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05619033 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 2.01763761 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.01259413 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97598745 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.90772124 |
| 26 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.88348538 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.88064007 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85758146 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84738014 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84068193 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.83579081 |
| 32 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.82549165 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80153452 |
| 34 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79188030 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76642241 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74347553 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.73891259 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72309481 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70960533 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69990945 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68610473 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67967875 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.64982090 |
| 44 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61405491 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61039415 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.57805262 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57053701 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55218166 |
| 49 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51481284 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49800701 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48996235 |
| 52 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47870558 |
| 53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.47110903 |
| 54 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.46439482 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45977727 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.45675073 |
| 57 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.45675073 |
| 58 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.44816769 |
| 59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.44190010 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43527291 |
| 61 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42599055 |
| 62 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42599055 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.40984350 |
| 64 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.38031134 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37870231 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35419405 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33479359 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33479359 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33096366 |
| 70 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32591243 |
| 71 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32269288 |
| 72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32099984 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32009613 |
| 74 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32009613 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31318451 |
| 76 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.30862731 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30680176 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30656624 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29849518 |
| 80 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.28918613 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28473854 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28419346 |
| 83 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.27164323 |
| 84 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.27089197 |
| 85 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25073735 |
| 86 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.24518160 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23888196 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23388987 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22259391 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22140905 |
| 91 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.22042302 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21995785 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20161019 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19802869 |
| 95 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19756084 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19637243 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18435785 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.18007300 |
| 99 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17848474 |
| 100 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15459750 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15284965 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14941255 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14465579 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14305952 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12724750 |
| 106 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12526445 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12241706 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12219929 |
| 109 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11360338 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10623282 |
| 111 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10572777 |
| 112 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10286508 |
| 113 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09935983 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09749207 |
| 115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08241125 |
| 116 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.07692310 |
| 117 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07537848 |
| 118 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07157366 |
| 119 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06619212 |
| 120 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06511565 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06359019 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06283174 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05671560 |
| 124 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05204977 |
| 125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04831475 |
| 126 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04467454 |
| 127 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03740126 |
| 128 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03405387 |
| 129 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03240752 |
| 130 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02827166 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02308534 |
| 132 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01347609 |
| 133 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01035743 |
| 134 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00348238 |
| 135 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98739634 |
| 136 | * JUN_21703547_ChIP-Seq_K562_Human | 0.98054392 |
| 137 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97748216 |
| 138 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.97244407 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96953532 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96597123 |
| 141 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96564574 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96411646 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95229994 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93910208 |
| 145 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93798313 |
| 146 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92486094 |
| 147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92349878 |
| 148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92042914 |
| 149 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90973375 |
| 150 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89583143 |
| 151 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.88410481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.90098675 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.85810488 |
| 3 | MP0006054_spinal_hemorrhage | 3.76906495 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.61710649 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.56703606 |
| 6 | MP0002736_abnormal_nociception_after | 3.50113011 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.36087933 |
| 8 | MP0003195_calcinosis | 3.10314578 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 3.09695955 |
| 10 | MP0001188_hyperpigmentation | 3.02703739 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.79975412 |
| 12 | MP0004270_analgesia | 2.55290297 |
| 13 | MP0005409_darkened_coat_color | 2.54597722 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.53760145 |
| 15 | MP0005171_absent_coat_pigmentation | 2.45128839 |
| 16 | MP0009745_abnormal_behavioral_response | 2.36683249 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.35197197 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.33013589 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.21713431 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.09966932 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.06832798 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 2.01926627 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.00670590 |
| 24 | MP0003787_abnormal_imprinting | 1.99080528 |
| 25 | MP0006276_abnormal_autonomic_nervous | 1.96760657 |
| 26 | MP0002693_abnormal_pancreas_physiology | 1.93443603 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.89719252 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.89433796 |
| 29 | MP0001944_abnormal_pancreas_morphology | 1.88472461 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.87831728 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.77892374 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.77574963 |
| 33 | MP0002272_abnormal_nervous_system | 1.74758096 |
| 34 | MP0001905_abnormal_dopamine_level | 1.74406740 |
| 35 | MP0010678_abnormal_skin_adnexa | 1.73350432 |
| 36 | MP0003724_increased_susceptibility_to | 1.72405931 |
| 37 | MP0002064_seizures | 1.71447736 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.71096529 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.70279153 |
| 40 | MP0001970_abnormal_pain_threshold | 1.66873928 |
| 41 | MP0001756_abnormal_urination | 1.64876135 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 1.62178678 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.61932477 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.59862041 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.55842577 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.55371955 |
| 47 | MP0002102_abnormal_ear_morphology | 1.53808945 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.53291551 |
| 49 | MP0003786_premature_aging | 1.50667265 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.49692646 |
| 51 | MP0005253_abnormal_eye_physiology | 1.48183896 |
| 52 | MP0002090_abnormal_vision | 1.47962145 |
| 53 | MP0005332_abnormal_amino_acid | 1.46907829 |
| 54 | MP0000681_abnormal_thyroid_gland | 1.45758004 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.45485276 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.43090033 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.41140223 |
| 58 | MP0005367_renal/urinary_system_phenotyp | 1.40041055 |
| 59 | MP0000516_abnormal_urinary_system | 1.40041055 |
| 60 | MP0005248_abnormal_Harderian_gland | 1.36945758 |
| 61 | MP0001542_abnormal_bone_strength | 1.35148160 |
| 62 | MP0001984_abnormal_olfaction | 1.35088777 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.33933472 |
| 64 | MP0005365_abnormal_bile_salt | 1.33928787 |
| 65 | MP0003252_abnormal_bile_duct | 1.33066874 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.32638557 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.32113049 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.31705699 |
| 69 | MP0002184_abnormal_innervation | 1.30936757 |
| 70 | MP0005503_abnormal_tendon_morphology | 1.30270688 |
| 71 | MP0004742_abnormal_vestibular_system | 1.30088451 |
| 72 | MP0003283_abnormal_digestive_organ | 1.28338888 |
| 73 | MP0002928_abnormal_bile_duct | 1.28038577 |
| 74 | MP0003828_pulmonary_edema | 1.27961484 |
| 75 | MP0009046_muscle_twitch | 1.27442441 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26783942 |
| 77 | MP0004484_altered_response_of | 1.26559555 |
| 78 | MP0002163_abnormal_gland_morphology | 1.26544871 |
| 79 | MP0001486_abnormal_startle_reflex | 1.25639059 |
| 80 | MP0000427_abnormal_hair_cycle | 1.25074114 |
| 81 | MP0002638_abnormal_pupillary_reflex | 1.23054936 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.21781201 |
| 83 | MP0008775_abnormal_heart_ventricle | 1.21312296 |
| 84 | MP0003136_yellow_coat_color | 1.20685012 |
| 85 | MP0003879_abnormal_hair_cell | 1.19021063 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.18307240 |
| 87 | MP0006292_abnormal_olfactory_placode | 1.18157365 |
| 88 | MP0002009_preneoplasia | 1.16215538 |
| 89 | MP0003045_fibrosis | 1.14507533 |
| 90 | MP0001764_abnormal_homeostasis | 1.08223816 |
| 91 | MP0003186_abnormal_redox_activity | 1.07514116 |
| 92 | MP0001661_extended_life_span | 1.06232531 |
| 93 | MP0003011_delayed_dark_adaptation | 1.06227970 |
| 94 | MP0002254_reproductive_system_inflammat | 1.05628860 |
| 95 | MP0004883_abnormal_blood_vessel | 1.04499361 |
| 96 | MP0004272_abnormal_basement_membrane | 1.04138100 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 1.03533491 |
| 98 | MP0005595_abnormal_vascular_smooth | 1.01392457 |
| 99 | MP0001502_abnormal_circadian_rhythm | 1.01193725 |
| 100 | MP0002557_abnormal_social/conspecific_i | 0.99917299 |
| 101 | MP0003941_abnormal_skin_development | 0.96959630 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.96358417 |
| 103 | MP0005164_abnormal_response_to | 0.96003651 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.95958150 |
| 105 | MP0001664_abnormal_digestion | 0.94413812 |
| 106 | MP0000778_abnormal_nervous_system | 0.94392158 |
| 107 | MP0004510_myositis | 0.93284448 |
| 108 | MP0001529_abnormal_vocalization | 0.91643530 |
| 109 | MP0009250_abnormal_appendicular_skeleto | 0.90923531 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.89961187 |
| 111 | MP0005187_abnormal_penis_morphology | 0.89598576 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.87599432 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.87580354 |
| 114 | MP0005165_increased_susceptibility_to | 0.86261830 |
| 115 | MP0000383_abnormal_hair_follicle | 0.86160012 |
| 116 | MP0008872_abnormal_physiological_respon | 0.84094394 |
| 117 | MP0001533_abnormal_skeleton_physiology | 0.83956432 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.83346735 |
| 119 | MP0003646_muscle_fatigue | 0.83050838 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.82807627 |
| 121 | MP0003191_abnormal_cellular_cholesterol | 0.82761439 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.81715797 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.81675764 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.81377058 |
| 125 | MP0000631_abnormal_neuroendocrine_gland | 0.80907837 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.80698307 |
| 127 | MP0004924_abnormal_behavior | 0.80531100 |
| 128 | MP0005386_behavior/neurological_phenoty | 0.80531100 |
| 129 | MP0003122_maternal_imprinting | 0.79718006 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.79716848 |
| 131 | MP0008569_lethality_at_weaning | 0.79671355 |
| 132 | MP0003121_genomic_imprinting | 0.78593808 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.78337810 |
| 134 | MP0005275_abnormal_skin_tensile | 0.78249033 |
| 135 | MP0002095_abnormal_skin_pigmentation | 0.77749798 |
| 136 | MP0003950_abnormal_plasma_membrane | 0.75427009 |
| 137 | MP0004043_abnormal_pH_regulation | 0.75188195 |
| 138 | MP0004885_abnormal_endolymph | 0.74876693 |
| 139 | MP0005410_abnormal_fertilization | 0.74764415 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.74437116 |
| 141 | MP0000371_diluted_coat_color | 0.74232538 |
| 142 | MP0002168_other_aberrant_phenotype | 0.73912703 |
| 143 | MP0005408_hypopigmentation | 0.73748513 |
| 144 | MP0008874_decreased_physiological_sensi | 0.72915604 |
| 145 | MP0005310_abnormal_salivary_gland | 0.72561565 |
| 146 | MP0005645_abnormal_hypothalamus_physiol | 0.72420931 |
| 147 | MP0002938_white_spotting | 0.71601384 |
| 148 | MP0005535_abnormal_body_temperature | 0.71435704 |
| 149 | MP0001346_abnormal_lacrimal_gland | 0.71399421 |
| 150 | MP0000647_abnormal_sebaceous_gland | 0.71264295 |
| 151 | MP0005390_skeleton_phenotype | 0.71090800 |
| 152 | MP0005448_abnormal_energy_balance | 0.71082674 |
| 153 | MP0005389_reproductive_system_phenotype | 0.70779791 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.70762816 |
| 155 | MP0000639_abnormal_adrenal_gland | 0.70354234 |
| 156 | MP0004085_abnormal_heartbeat | 0.70161652 |
| 157 | MP0003279_aneurysm | 0.69408072 |
| 158 | MP0003137_abnormal_impulse_conducting | 0.67907723 |
| 159 | MP0002229_neurodegeneration | 0.67784431 |
| 160 | MP0009785_altered_susceptibility_to | 0.65980828 |
| 161 | MP0003633_abnormal_nervous_system | 0.64478846 |
| 162 | MP0008260_abnormal_autophagy | 0.64397087 |
| 163 | MP0000026_abnormal_inner_ear | 0.63807339 |
| 164 | MP0000678_abnormal_parathyroid_gland | 0.63723743 |
| 165 | MP0000762_abnormal_tongue_morphology | 0.63090456 |
| 166 | MP0002249_abnormal_larynx_morphology | 0.62961446 |
| 167 | MP0000163_abnormal_cartilage_morphology | 0.62156116 |
| 168 | MP0008004_abnormal_stomach_pH | 0.60284657 |
| 169 | MP0004858_abnormal_nervous_system | 0.60187790 |
| 170 | MP0001851_eye_inflammation | 0.59971057 |
| 171 | MP0002282_abnormal_trachea_morphology | 0.59826086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.31813794 |
| 2 | Hyperventilation (HP:0002883) | 4.44487685 |
| 3 | Hypothermia (HP:0002045) | 4.20872944 |
| 4 | Epileptic encephalopathy (HP:0200134) | 3.65492026 |
| 5 | Myokymia (HP:0002411) | 3.57517828 |
| 6 | Intestinal atresia (HP:0011100) | 3.54673452 |
| 7 | Febrile seizures (HP:0002373) | 3.49938381 |
| 8 | Atonic seizures (HP:0010819) | 3.48692108 |
| 9 | Glucose intolerance (HP:0000833) | 3.39113410 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.36704459 |
| 11 | Pancreatic cysts (HP:0001737) | 3.10887011 |
| 12 | Abnormality of vitamin B metabolism (HP:0004340) | 3.10179816 |
| 13 | Focal seizures (HP:0007359) | 3.04280452 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.02017940 |
| 15 | Hemiparesis (HP:0001269) | 2.96466920 |
| 16 | Enlarged penis (HP:0000040) | 2.94965131 |
| 17 | Broad-based gait (HP:0002136) | 2.87393870 |
| 18 | Hyperglycemia (HP:0003074) | 2.83461075 |
| 19 | Epiphyseal dysplasia (HP:0002656) | 2.81629676 |
| 20 | Increased CSF protein (HP:0002922) | 2.79723537 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 2.78834916 |
| 22 | Large for gestational age (HP:0001520) | 2.77551737 |
| 23 | Congenital malformation of the right heart (HP:0011723) | 2.77261014 |
| 24 | Double outlet right ventricle (HP:0001719) | 2.77261014 |
| 25 | Amblyopia (HP:0000646) | 2.76352850 |
| 26 | Glycosuria (HP:0003076) | 2.72504916 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 2.72504916 |
| 28 | Abnormal glucose tolerance (HP:0001952) | 2.70878197 |
| 29 | Vascular calcification (HP:0004934) | 2.69527123 |
| 30 | Abnormality of the renal cortex (HP:0011035) | 2.66192021 |
| 31 | Metaphyseal dysplasia (HP:0100255) | 2.65215338 |
| 32 | Inability to walk (HP:0002540) | 2.64900522 |
| 33 | Ulnar claw (HP:0001178) | 2.63402648 |
| 34 | Xerostomia (HP:0000217) | 2.62743185 |
| 35 | Hematochezia (HP:0002573) | 2.60536075 |
| 36 | Ketoacidosis (HP:0001993) | 2.59490555 |
| 37 | Increased CSF lactate (HP:0002490) | 2.57818972 |
| 38 | Tongue fasciculations (HP:0001308) | 2.52291619 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.50862683 |
| 40 | Methylmalonic acidemia (HP:0002912) | 2.50003437 |
| 41 | Acute encephalopathy (HP:0006846) | 2.48967291 |
| 42 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.47710525 |
| 43 | Heterochromia iridis (HP:0001100) | 2.42678333 |
| 44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.40783789 |
| 45 | Congenital stationary night blindness (HP:0007642) | 2.40001143 |
| 46 | Abnormality of vitamin metabolism (HP:0100508) | 2.39095641 |
| 47 | Visual hallucinations (HP:0002367) | 2.39005423 |
| 48 | Absence seizures (HP:0002121) | 2.37247393 |
| 49 | Nonprogressive disorder (HP:0003680) | 2.36921716 |
| 50 | Conjunctival hamartoma (HP:0100780) | 2.34981283 |
| 51 | Corneal dystrophy (HP:0001131) | 2.33267466 |
| 52 | Submucous cleft hard palate (HP:0000176) | 2.33019996 |
| 53 | Abnormality of midbrain morphology (HP:0002418) | 2.32573539 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.32573539 |
| 55 | Hydroureter (HP:0000072) | 2.31612018 |
| 56 | Postural tremor (HP:0002174) | 2.30275166 |
| 57 | Tubular atrophy (HP:0000092) | 2.29679122 |
| 58 | Abnormality of renal resorption (HP:0011038) | 2.29138279 |
| 59 | Hepatic necrosis (HP:0002605) | 2.28735294 |
| 60 | Furrowed tongue (HP:0000221) | 2.28451585 |
| 61 | Albinism (HP:0001022) | 2.27876868 |
| 62 | Patchy hypopigmentation of hair (HP:0011365) | 2.27608064 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.26158238 |
| 64 | Hamartoma of the eye (HP:0010568) | 2.24153909 |
| 65 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.23765687 |
| 66 | Dialeptic seizures (HP:0011146) | 2.22713060 |
| 67 | Hypoplasia of the fovea (HP:0007750) | 2.22654039 |
| 68 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.22654039 |
| 69 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.21860483 |
| 70 | Increased hepatocellular lipid droplets (HP:0006565) | 2.20859240 |
| 71 | Fragile nails (HP:0001808) | 2.20023111 |
| 72 | Amelogenesis imperfecta (HP:0000705) | 2.19010492 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.16448144 |
| 74 | Delusions (HP:0000746) | 2.13866084 |
| 75 | Urethral obstruction (HP:0000796) | 2.13298531 |
| 76 | Neoplasm of the adrenal cortex (HP:0100641) | 2.13283739 |
| 77 | White forelock (HP:0002211) | 2.12779538 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.12521873 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 2.12328501 |
| 80 | Constricted visual fields (HP:0001133) | 2.11996906 |
| 81 | Thickened helices (HP:0000391) | 2.11863287 |
| 82 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.11621202 |
| 83 | Dysautonomia (HP:0002459) | 2.11616749 |
| 84 | Cerebral edema (HP:0002181) | 2.11154155 |
| 85 | Abnormality of renal excretion (HP:0011036) | 2.10684611 |
| 86 | Abnormal drinking behavior (HP:0030082) | 2.09433971 |
| 87 | Polydipsia (HP:0001959) | 2.09433971 |
| 88 | Abnormality of the axillary hair (HP:0100134) | 2.09077405 |
| 89 | Abnormality of secondary sexual hair (HP:0009888) | 2.09077405 |
| 90 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09071826 |
| 91 | Polyphagia (HP:0002591) | 2.08987452 |
| 92 | Growth hormone excess (HP:0000845) | 2.08505028 |
| 93 | Nephronophthisis (HP:0000090) | 2.08314897 |
| 94 | Methylmalonic aciduria (HP:0012120) | 2.07781107 |
| 95 | Respiratory failure (HP:0002878) | 2.07408369 |
| 96 | Aqueductal stenosis (HP:0002410) | 2.07353034 |
| 97 | Medial flaring of the eyebrow (HP:0010747) | 2.06968703 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 2.06851944 |
| 99 | Retinal dysplasia (HP:0007973) | 2.05692887 |
| 100 | Neonatal short-limb short stature (HP:0008921) | 2.05526294 |
| 101 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05311409 |
| 102 | Muscle fibrillation (HP:0010546) | 2.04560592 |
| 103 | Abnormality of the renal medulla (HP:0100957) | 2.04414675 |
| 104 | Acute necrotizing encephalopathy (HP:0006965) | 2.02323196 |
| 105 | Protruding tongue (HP:0010808) | 2.02057225 |
| 106 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01967566 |
| 107 | Irregular epiphyses (HP:0010582) | 2.01921683 |
| 108 | Palpebral edema (HP:0100540) | 2.01170080 |
| 109 | Vacuolated lymphocytes (HP:0001922) | 1.99754015 |
| 110 | Renal cortical cysts (HP:0000803) | 1.98828878 |
| 111 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98371987 |
| 112 | Ketosis (HP:0001946) | 1.98270798 |
| 113 | Progressive inability to walk (HP:0002505) | 1.96080911 |
| 114 | Hypertensive crisis (HP:0100735) | 1.95924947 |
| 115 | Orthostatic hypotension (HP:0001278) | 1.95775704 |
| 116 | Abnormality of binocular vision (HP:0011514) | 1.94451587 |
| 117 | Diplopia (HP:0000651) | 1.94451587 |
| 118 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.94032240 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94002656 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94002656 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94002656 |
| 122 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93499666 |
| 123 | Genu varum (HP:0002970) | 1.93113642 |
| 124 | Progressive neurologic deterioration (HP:0002344) | 1.92953489 |
| 125 | Abnormality of salivation (HP:0100755) | 1.92880372 |
| 126 | Neuroendocrine neoplasm (HP:0100634) | 1.92772490 |
| 127 | Action tremor (HP:0002345) | 1.92762852 |
| 128 | Short tibia (HP:0005736) | 1.92222756 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.91328124 |
| 130 | Disproportionate short-trunk short stature (HP:0003521) | 1.91170487 |
| 131 | Anxiety (HP:0000739) | 1.90908288 |
| 132 | Alveolar cell carcinoma (HP:0006519) | 1.90594013 |
| 133 | Type II lissencephaly (HP:0007260) | 1.90405110 |
| 134 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.89947081 |
| 135 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.89187155 |
| 136 | Mitochondrial inheritance (HP:0001427) | 1.88287965 |
| 137 | Generalized tonic-clonic seizures (HP:0002069) | 1.87544781 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85287798 |
| 139 | Mucopolysacchariduria (HP:0008155) | 1.85287798 |
| 140 | Progressive macrocephaly (HP:0004481) | 1.84632644 |
| 141 | Vitreoretinal degeneration (HP:0000655) | 1.82930856 |
| 142 | Abnormality of the fovea (HP:0000493) | 1.82888573 |
| 143 | Abnormal hair whorl (HP:0010721) | 1.82862220 |
| 144 | Abnormal urine output (HP:0012590) | 1.81684720 |
| 145 | Palpitations (HP:0001962) | 1.80928586 |
| 146 | Abolished electroretinogram (ERG) (HP:0000550) | 1.79480676 |
| 147 | Neoplasm of the adrenal gland (HP:0100631) | 1.79464335 |
| 148 | Fair hair (HP:0002286) | 1.79457580 |
| 149 | Onycholysis (HP:0001806) | 1.79406943 |
| 150 | True hermaphroditism (HP:0010459) | 1.79304179 |
| 151 | Stomatitis (HP:0010280) | 1.79033958 |
| 152 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.78925288 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.78746675 |
| 154 | Pheochromocytoma (HP:0002666) | 1.78123516 |
| 155 | Decreased central vision (HP:0007663) | 1.77427789 |
| 156 | Prostate neoplasm (HP:0100787) | 1.77278584 |
| 157 | Bradycardia (HP:0001662) | 1.77050159 |
| 158 | Fetal akinesia sequence (HP:0001989) | 1.76976277 |
| 159 | Congenital hepatic fibrosis (HP:0002612) | 1.76943639 |
| 160 | Abnormal biliary tract physiology (HP:0012439) | 1.76813463 |
| 161 | Bile duct proliferation (HP:0001408) | 1.76813463 |
| 162 | Absent speech (HP:0001344) | 1.76788681 |
| 163 | Agitation (HP:0000713) | 1.76579180 |
| 164 | Exotropia (HP:0000577) | 1.74854443 |
| 165 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74596626 |
| 166 | Gait imbalance (HP:0002141) | 1.70258354 |
| 167 | Blue irides (HP:0000635) | 1.69579276 |
| 168 | Testicular atrophy (HP:0000029) | 1.69299357 |
| 169 | Renal Fanconi syndrome (HP:0001994) | 1.68735445 |
| 170 | Follicular hyperkeratosis (HP:0007502) | 1.68311826 |
| 171 | Prominent supraorbital ridges (HP:0000336) | 1.68052479 |
| 172 | Flat capital femoral epiphysis (HP:0003370) | 1.67984012 |
| 173 | J-shaped sella turcica (HP:0002680) | 1.67758769 |
| 174 | Hypoventilation (HP:0002791) | 1.67039761 |
| 175 | Mixed hearing impairment (HP:0000410) | 1.66776459 |
| 176 | Congenital primary aphakia (HP:0007707) | 1.66765675 |
| 177 | Nephrogenic diabetes insipidus (HP:0009806) | 1.66726926 |
| 178 | Narrow nasal bridge (HP:0000446) | 1.65950556 |
| 179 | Abnormality of dental color (HP:0011073) | 1.64860688 |
| 180 | Absent eyebrow (HP:0002223) | 1.64166972 |
| 181 | Hepatocellular necrosis (HP:0001404) | 1.63493269 |
| 182 | Limb dystonia (HP:0002451) | 1.58893096 |
| 183 | Drooling (HP:0002307) | 1.57948966 |
| 184 | Excessive salivation (HP:0003781) | 1.57948966 |
| 185 | Generalized hypopigmentation of hair (HP:0011358) | 1.57809728 |
| 186 | Hyperthyroidism (HP:0000836) | 1.56674883 |
| 187 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.56583507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.81827472 |
| 2 | MAP3K12 | 3.85514875 |
| 3 | RIPK4 | 3.85496281 |
| 4 | EPHA4 | 3.35808251 |
| 5 | ACVR1B | 3.23505863 |
| 6 | INSRR | 3.05901424 |
| 7 | WNK3 | 2.93553334 |
| 8 | GRK5 | 2.81054216 |
| 9 | EIF2AK3 | 2.80327922 |
| 10 | BMPR2 | 2.78579935 |
| 11 | NTRK3 | 2.55567864 |
| 12 | MAP4K2 | 2.51463442 |
| 13 | MAP2K7 | 2.28917205 |
| 14 | STK39 | 2.17495432 |
| 15 | PLK2 | 2.14646060 |
| 16 | FGFR2 | 2.10668023 |
| 17 | SIK3 | 2.02735977 |
| 18 | OXSR1 | 2.01585052 |
| 19 | BMPR1B | 1.95934573 |
| 20 | EIF2AK1 | 1.94354163 |
| 21 | PTK2B | 1.91663461 |
| 22 | TRIM28 | 1.91359971 |
| 23 | MST4 | 1.77938990 |
| 24 | GRK7 | 1.73373985 |
| 25 | ARAF | 1.72253537 |
| 26 | TIE1 | 1.71196714 |
| 27 | PHKG2 | 1.65795185 |
| 28 | PHKG1 | 1.65795185 |
| 29 | TNIK | 1.61884048 |
| 30 | NME1 | 1.58877421 |
| 31 | DAPK2 | 1.53737322 |
| 32 | MUSK | 1.53557660 |
| 33 | DAPK1 | 1.51016681 |
| 34 | AKT3 | 1.43729295 |
| 35 | CAMKK2 | 1.39621939 |
| 36 | MYLK | 1.38706790 |
| 37 | CSNK1G1 | 1.36204615 |
| 38 | FER | 1.32375176 |
| 39 | MKNK1 | 1.30313154 |
| 40 | PAK3 | 1.26067662 |
| 41 | PLK3 | 1.10354079 |
| 42 | STK3 | 1.07635485 |
| 43 | CSNK1G2 | 1.05043169 |
| 44 | CDK19 | 1.04601838 |
| 45 | ADRBK2 | 1.04275448 |
| 46 | CSNK1G3 | 1.03939277 |
| 47 | PRKCE | 1.03599096 |
| 48 | MAP3K4 | 1.03381414 |
| 49 | PIM2 | 1.02839855 |
| 50 | MINK1 | 1.01175625 |
| 51 | BCR | 1.00789811 |
| 52 | CAMK2A | 0.98108984 |
| 53 | PINK1 | 0.96397374 |
| 54 | MKNK2 | 0.94016912 |
| 55 | CAMK2B | 0.93029891 |
| 56 | TAF1 | 0.92577839 |
| 57 | FGR | 0.91820957 |
| 58 | TAOK2 | 0.90593455 |
| 59 | STK38L | 0.89703484 |
| 60 | CSNK1A1L | 0.88491611 |
| 61 | FES | 0.86249883 |
| 62 | FGFR3 | 0.84815374 |
| 63 | STK24 | 0.82872280 |
| 64 | MAP3K14 | 0.82761064 |
| 65 | MAPKAPK5 | 0.81758452 |
| 66 | CDK8 | 0.80416168 |
| 67 | BRSK2 | 0.79594338 |
| 68 | NME2 | 0.79248751 |
| 69 | SIK2 | 0.78739717 |
| 70 | NTRK1 | 0.77643380 |
| 71 | TGFBR1 | 0.77497225 |
| 72 | ADRBK1 | 0.76963501 |
| 73 | MAP2K1 | 0.76288155 |
| 74 | STK16 | 0.75658497 |
| 75 | MAP2K4 | 0.74493359 |
| 76 | ERBB3 | 0.73580880 |
| 77 | PLK4 | 0.73434849 |
| 78 | MAP3K3 | 0.72171451 |
| 79 | EPHA3 | 0.71696417 |
| 80 | CCNB1 | 0.71315488 |
| 81 | YES1 | 0.70385234 |
| 82 | MAPK12 | 0.69844301 |
| 83 | MAP3K2 | 0.69724902 |
| 84 | MAP3K9 | 0.66605892 |
| 85 | MAP3K13 | 0.64984904 |
| 86 | MAPK13 | 0.64550851 |
| 87 | NLK | 0.64402549 |
| 88 | PRPF4B | 0.63816625 |
| 89 | PRKCG | 0.62613812 |
| 90 | MAP3K1 | 0.62350595 |
| 91 | WNK4 | 0.62233640 |
| 92 | CDK5 | 0.61945669 |
| 93 | CDK3 | 0.61682369 |
| 94 | TGFBR2 | 0.58403021 |
| 95 | EIF2AK2 | 0.58025112 |
| 96 | GRK1 | 0.57750168 |
| 97 | CAMK2D | 0.57587196 |
| 98 | TAOK3 | 0.55688858 |
| 99 | DYRK1A | 0.54922752 |
| 100 | BCKDK | 0.54405145 |
| 101 | PIK3CA | 0.54118094 |
| 102 | MST1R | 0.52818532 |
| 103 | CAMK1 | 0.52022321 |
| 104 | MOS | 0.51699806 |
| 105 | NEK6 | 0.51355744 |
| 106 | SGK2 | 0.51089437 |
| 107 | EPHB2 | 0.50392693 |
| 108 | TEC | 0.48826953 |
| 109 | MAPK15 | 0.48773557 |
| 110 | PRKCI | 0.48206908 |
| 111 | SYK | 0.47270016 |
| 112 | NUAK1 | 0.47256810 |
| 113 | BRAF | 0.45269620 |
| 114 | PIK3CG | 0.44327254 |
| 115 | SGK494 | 0.43649886 |
| 116 | SGK223 | 0.43649886 |
| 117 | STK10 | 0.43277724 |
| 118 | WEE1 | 0.42335847 |
| 119 | MAP2K6 | 0.41929338 |
| 120 | DAPK3 | 0.41693431 |
| 121 | PRKG2 | 0.41240194 |
| 122 | ZAK | 0.40955116 |
| 123 | TLK1 | 0.40432228 |
| 124 | RAF1 | 0.38884501 |
| 125 | PRKAA2 | 0.38671327 |
| 126 | IKBKB | 0.37875355 |
| 127 | STK11 | 0.36533541 |
| 128 | IKBKE | 0.36051329 |
| 129 | PRKACA | 0.35832034 |
| 130 | TRPM7 | 0.33763365 |
| 131 | IRAK1 | 0.33500304 |
| 132 | VRK2 | 0.33232843 |
| 133 | CSNK1A1 | 0.32927427 |
| 134 | PRKD3 | 0.32647524 |
| 135 | GSK3A | 0.32338130 |
| 136 | PRKCD | 0.32283326 |
| 137 | PRKCQ | 0.32214534 |
| 138 | FRK | 0.31852181 |
| 139 | PRKG1 | 0.31566149 |
| 140 | VRK1 | 0.30974172 |
| 141 | CAMK2G | 0.30628117 |
| 142 | GRK6 | 0.30097104 |
| 143 | AKT2 | 0.29687095 |
| 144 | TNK2 | 0.28347651 |
| 145 | ABL1 | 0.27764392 |
| 146 | KDR | 0.27667484 |
| 147 | ROCK2 | 0.27528069 |
| 148 | PLK1 | 0.27386195 |
| 149 | STK4 | 0.27260570 |
| 150 | MAPKAPK3 | 0.26562448 |
| 151 | CSNK1D | 0.26431002 |
| 152 | ROCK1 | 0.25933079 |
| 153 | BUB1 | 0.24990083 |
| 154 | EGFR | 0.23597311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.61883394 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.21639992 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.97018583 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.90991907 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.57071054 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.48623290 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.40235684 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32220410 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.27921011 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27393032 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27249680 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.12415862 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.11613366 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.09588513 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.07873510 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02150139 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.00472581 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.89770040 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.89533087 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.87315956 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.85444337 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.84861959 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81465156 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.80568729 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77052240 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76196088 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.76013177 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.65610798 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.65218231 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.60543717 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.58755479 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.58546357 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55763047 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55666877 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.55082794 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.55030220 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.53052952 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47032280 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46886433 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.41236338 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38770847 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.38046045 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36022620 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.34721201 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.27485620 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26654883 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26519087 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26006267 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25430869 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24985854 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24596377 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22284299 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13664502 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13336123 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 1.12332218 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11612055 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.11474094 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10924212 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10486322 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10163988 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09459103 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07085807 |
| 63 | Cocaine addiction_Homo sapiens_hsa05030 | 1.05933038 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05888297 |
| 65 | Homologous recombination_Homo sapiens_hsa03440 | 1.04523534 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04118099 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 1.02811881 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01821172 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01439105 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.00690817 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.99326197 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99101371 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98794687 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.95646002 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95144751 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94443003 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93941332 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92993578 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92973875 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91635309 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89105821 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88989846 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85123994 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84502039 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84457451 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.84324558 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84299126 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84122557 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82093542 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78424691 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77108120 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77105102 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76910239 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76739817 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76660879 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75460202 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75176964 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75108607 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.75039246 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74085106 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.72681804 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70753735 |
| 103 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70109828 |
| 104 | Protein export_Homo sapiens_hsa03060 | 0.70006274 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.69035151 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69002744 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.68622007 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68393155 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67799622 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67074979 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66751255 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65719068 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.65522774 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65253389 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64499633 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64138665 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63868686 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63413008 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62565741 |
| 120 | RNA degradation_Homo sapiens_hsa03018 | 0.61729672 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.60705646 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.60703146 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59698100 |
| 124 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59273918 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58069178 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57430455 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.57355166 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56894162 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56514586 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55939918 |
| 131 | RNA polymerase_Homo sapiens_hsa03020 | 0.55894817 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.55749873 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55729457 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.55569177 |
| 135 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55380287 |
| 136 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.53709530 |
| 137 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53061529 |
| 138 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52456604 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51409095 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50546211 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49355487 |
| 142 | Tuberculosis_Homo sapiens_hsa05152 | 0.49030167 |
| 143 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48649052 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48181093 |
| 145 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48098186 |
| 146 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48027365 |
| 147 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47596502 |
| 148 | Allograft rejection_Homo sapiens_hsa05330 | 0.47398260 |
| 149 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46659406 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46199189 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45813595 |
| 152 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45594036 |
| 153 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44652468 |
| 154 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43615702 |
| 155 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43552297 |
| 156 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43308407 |
| 157 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42644556 |
| 158 | Asthma_Homo sapiens_hsa05310 | 0.41622055 |
| 159 | Shigellosis_Homo sapiens_hsa05131 | 0.40562766 |
| 160 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39771856 |
| 161 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38186678 |
| 162 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38177354 |
| 163 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37917765 |
| 164 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37453739 |

